Eternal Energy Valuation
Is EE-R undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
2/6Valuation Score 2/6
Below Fair Value
Significantly Below Fair Value
Price-To-Book vs Peers
Price-To-Book vs Industry
Price-To-Book vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of EE-R when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: Insufficient data to calculate EE-R's fair value for valuation analysis.
Significantly Below Fair Value: Insufficient data to calculate EE-R's fair value for valuation analysis.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for EE-R?
Key metric: As EE-R barely has revenue we use its Price-To-Book Ratio for relative valuation analysis.
| What is EE-R's PB Ratio? | |
|---|---|
| PB Ratio | 0.7x |
| Book | ฿804.56m |
| Market Cap | ฿556.00m |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 318.8x |
| Enterprise Value/EBITDA | -14.7x |
| PEG Ratio | n/a |
Price to Book Ratio vs Peers
How does EE-R's PB Ratio compare to its peers?
| Company | Forward PB | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 4.6x | ||
JSP JSP Pharmaceutical Manufacturing (Thailand) Public | 1.1x | n/a | ฿968.1m |
BLC Bangkok Lab And Cosmetic | 2x | n/a | ฿3.3b |
TMAN T.Man Pharmaceutical | 11.9x | n/a | ฿6.2b |
MEGA Mega Lifesciences | 3.4x | 14.7% | ฿31.4b |
EE-R Eternal Energy | 0.7x | n/a | ฿556.0m |
Price-To-Book vs Peers: EE-R is good value based on its Price-To-Book Ratio (0.7x) compared to the peer average (4.6x).
Price to Book Ratio vs Industry
How does EE-R's PB Ratio compare vs other companies in the Asian Pharmaceuticals Industry?
| 20 Companies | Price / Book | Estimated Growth | Market Cap |
|---|---|---|---|
| 20 Companies | Estimated Growth | Market Cap | |
|---|---|---|---|
Price-To-Book vs Industry: EE-R is good value based on its Price-To-Book Ratio (0.7x) compared to the Asian Pharmaceuticals industry average (2.1x).
Price to Book Ratio vs Fair Ratio
What is EE-R's PB Ratio compared to its Fair PB Ratio? This is the expected PB Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PB Ratio | 0.7x |
| Fair PB Ratio | n/a |
Price-To-Book vs Fair Ratio: Insufficient data to calculate EE-R's Price-To-Book Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.